Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nishio

Showing results (401-410 of 409) with videos related to

Pageof 41
Sort By:
You have reached the last page of results.This site can display upto 409 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 25, 2015
A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trialK Kubota, H Sakai, N Katakami, et al.
Nature Communications|March 30, 2016
Interplanar coupling-dependent magnetoresistivity in high-purity layered metalsN Kikugawa, P Goswami, A Kiswandhi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 27, 2010
Increased risk of bacterial infection after engraftment in patients treated with allogeneic bone marrow transplantation following reduced-intensity conditioning regimenA Shigematsu, S Yamamoto, J Sugita, et al.
Oncogene|December 9, 2014
Abrogation of protein phosphatase 6 promotes skin carcinogenesis induced by DMBAK Hayashi, Y Momoi, N Tanuma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 2021
Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancerS Sugawara, J-S Lee, J-H Kang, et al.
ESMO Open|July 17, 2022
Final overall survival analysis from the phase III J-ALEX study of alectinib versus crizotinib in ALK inhibitor-naïve Japanese patients with ALK-positive non-small-cell lung cancerK Hotta, T Hida, H Nokihara, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)H Nokihara, S Lu, T S K Mok, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2022
Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small-cell lung cancer: a pooled analysisH Borghaei, T-E Ciuleanu, J-S Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2024
Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLCH A Yu, C Baik, D-W Kim, et al.
Pageof 41

Showing results (401-410 of 409) with videos related to

Sort By:
Pageof 41
You have reached the last page of results.This site can display upto 409 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 25, 2015
A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trialK Kubota, H Sakai, N Katakami, et al.
Nature Communications|March 30, 2016
Interplanar coupling-dependent magnetoresistivity in high-purity layered metalsN Kikugawa, P Goswami, A Kiswandhi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 27, 2010
Increased risk of bacterial infection after engraftment in patients treated with allogeneic bone marrow transplantation following reduced-intensity conditioning regimenA Shigematsu, S Yamamoto, J Sugita, et al.
Oncogene|December 9, 2014
Abrogation of protein phosphatase 6 promotes skin carcinogenesis induced by DMBAK Hayashi, Y Momoi, N Tanuma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 2021
Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancerS Sugawara, J-S Lee, J-H Kang, et al.
ESMO Open|July 17, 2022
Final overall survival analysis from the phase III J-ALEX study of alectinib versus crizotinib in ALK inhibitor-naïve Japanese patients with ALK-positive non-small-cell lung cancerK Hotta, T Hida, H Nokihara, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)H Nokihara, S Lu, T S K Mok, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2022
Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small-cell lung cancer: a pooled analysisH Borghaei, T-E Ciuleanu, J-S Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2024
Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLCH A Yu, C Baik, D-W Kim, et al.
Pageof 41